Indoco Remedies Limited (INDOCO.NS) NSE

208.01

+0.76(+0.37%)

Updated at June 03 11:05AM

Currency In INR

Valuation

Market Cap14.58B
Enterprise Value25.15B
P/E Ratio-17.96
PEG Ratio0.43
Price/Sales Ratio1.05
Price/Book Ratio1.86
Enterprise/Revenue1.63
Enterprise/EBITDA20.65

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.05
Operating Margin0.01

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.1

Income Statement

Revenue18.45B
Revenue/Share216.37
Gross Profit7.51B
EBITDA1.42B
Net Income-987M
Diluted EPS-10.69

Balance Sheet

Total Cash329.9M
Total Cash/Share3.92
Total Debt10.9B
Total Debt/Equity1.16
Current Ratio1.13
Book Value Per Share110.7

Price History

52-Week Change-19.97
52-Week High349.8
52-Week Low162.19
Moving Average 50 Days206.49
Moving Average 200 Days235.71

Statistics

Average Volume113,507
Shares Outstanding92.17M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield0.1
Payout Ratio-0.02
Last Split Factor5:1
Last Split DateMay 17, 2012